https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/funding-develop-immunotherapy-childhood-sarcomas-0/
Funding to develop immunotherapy for childhood sarcomas
18 Dec 2015, 1:01 p.m.

Biomedical Research Centre (BRC) supported Professor John Anderson has been awarded funding from Children with Cancer UK to investigate new immunotherapy approaches for childhood sarcomas.If successful, the team plan to develop a new clinical trial to test this treatment. Such a trial will increase the treatment options for young sarcoma patients at relapse, where chemotherapy has failed.
Professor Anderson and his team plan to use an approach called adoptive immunotherapy – first, doctors take a sample of a patient’s own blood cells. In the lab, these cells are then genetically modified to recognise a particular target (called an antigen) and then injected back into the patient. Once these genetically modified cells, called chimeric antigen receptors (CARs), come into contact with the antigen, these cells activate the patient’s immune system to fight the cell.
The team have already successfully used this approach to treat chemotherapy-resistant neuroblastomas, and a trial is now underway at Great Ormond Street Hospital to investigate this treatment option for sarcoma, solid tumours that can occur in the bone or soft tissue, which include Ewing sarcoma, osteosarcoma and rhabdomyosarcoma. These cancers have a dismal prognosis if they relapse or metastasise. Only about 1% of adults with cancer suffer from sarcoma, but 15% of children with cancer suffer from sarcoma.

Teenager off to university after life-changing gene therapy
A teenager with a rare, life-limiting genetic condition is off to university after receiving a gene therapy that changed his life.

Stem cell treatment can improve rare skin condition in children
Children with a rare skin condition have found their symptoms have improved through taking part in the largest clinical trial of its kind, led by clinicians at Great Ormond Street Hospital for Children (GOSH).

Young people donate tissue samples to unlock mysteries of arthritis
A new groundbreaking study led by researchers at the University of Birmingham, Great Ormond Street Hospital, University College London and Birmingham Children’s Hospital has revealed important clues into what is driving arthritis in children.

Toddler doing well after receiving newest gene therapy available on NHS
A toddler with a life-limiting and life-threatening rare disease is the youngest to be treated with the newest gene therapy available on the NHS at GOSH.